Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy

Thromb Haemost. 2020 Aug;120(8):1233-1236. doi: 10.1055/s-0040-1712918. Epub 2020 May 26.

Authors

Affiliations

¹ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
² Department of Cardiotoracovascolare, Azienda Ospedaliero-Universitaria Careggi Firenze, Firenze, Italy.

PMID: 32455440
DOI: 10.1055/s-0040-1712918

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Humans
Italy
Pandemics*
Pneumonia, Viral*
Prognosis
SARS-CoV-2

Substances

Anticoagulants